| Non-vulnerable region | Vulnerable region | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3-month mortality | 6-month mortality | 1-year Mortality | ||||||||||||
Adjusted HR | Adjusted HR* | 95% CI | Adjusted HR* | 95% CI | Adjusted HR* | 95% CI | ||||||||
Pancreatic Cancer Treatment | ||||||||||||||
 Yes | 1.00 | 1.05 | (0.49 | - | 2.21) | 1.20 | (0.78 | - | 1.85) | 1.01 | (0.74 | - | 1.38) | |
 No | 1.00 | 1.36 | (1.07 | - | 1.72) | 1.23 | (1.00 | - | 1.51) | 1.17 | (0.97 | - | 1.41) | |
Sex | ||||||||||||||
 Male | 1.00 | 1.62 | (1.22 | - | 2.15) | 1.54 | (1.22 | - | 1.94) | 1.30 | (1.06 | - | 1.60) | |
 Female | 1.00 | 1.00 | (0.68 | - | 1.47) | 0.91 | (0.67 | - | 1.24) | 0.94 | (0.73 | - | 1.22) | |
Household income | ||||||||||||||
 Low | 1.00 | 1.64 | (1.00 | - | 2.70) | 1.40 | (0.93 | - | 2.09) | 1.45 | (1.04 | - | 2.04) | |
 Mid-low | 1.00 | 1.33 | (0.88 | - | 2.01) | 1.31 | (0.94 | - | 1.82) | 1.13 | (0.85 | - | 1.52) | |
 Mid-high | 1.00 | 1.17 | (0.82 | - | 1.67) | 1.17 | (0.88 | - | 1.56) | 1.07 | (0.83 | - | 1.37) |